Labshake search
Citations for Abbott :
1 - 16 of 16 citations for Anti mGLUR6 Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: Sera were tested for anti-nucleoprotein (NP) IgG antibodies (CMIA, Abbott Laboratories) on an Abbott Architect i2000SR automated instrument ...
-
bioRxiv - Immunology 2022Quote: ... in the absence or presence of anti-IL-17A mAb (secukinumab, Novartis) and/or anti-TNFα blocking antibodies (adalimumab, Abbott Laboratories) or isotype control mAb (all human IgG1 and added at 5μg/mL).
-
bioRxiv - Microbiology 2019Quote: Anti-HCV antibodies in patients’ sera were qualitatively screened using a chemiluminescent microparticle immunoassay (CMIA-ARCHITECHT3; ABBOTT). Recombinant blot immunoassay (RIBA ...
-
bioRxiv - Pathology 2020Quote: ... NK-!R antibody (Abbott, 1:1000) was applied and incubated for 30 min at 37 °C ...
-
bioRxiv - Immunology 2021Quote: ... Detection of serum SARS-CoV-2 IgG and IgM antibodies was evaluated by IgM/IgG antibody detection kit (Abbott Laboratories, Inc).
-
bioRxiv - Immunology 2021Quote: Architect Anti-SARS-CoV2 IgG assay (Abbott Laboratories, Chicago, IL): This assay is an automated ...
-
bioRxiv - Immunology 2022Quote: The level of anti-RBD IgG antibodies was measured in human plasma by chemiluminescent microparticle assay (CMIA) using the SARS-CoV-2 IgG II Quant (Abbott, USA) on the ARCHITECT I System (Abbott ...
-
bioRxiv - Immunology 2021Quote: ... marked assays were used to determine the presence of SARS-CoV-2-specific antibodies in serum specimens: Architect SARS-CoV-2 IgG (6R86, Abbott, Illinois, USA) detecting anti-nucleocapsid antibodies and Anti-SARS-CoV-2-ELISA IgG (EI 2606-9601 G ...
-
bioRxiv - Immunology 2024Quote: ... we also used the ARCHITECT i2000SR high-throughput system anti-nucleocapsid (N) IgG (Abbott, Illinois, USA), diagnostic kit.
-
bioRxiv - Molecular Biology 2022Quote: ... used for quantitative determination of IgG antibodies to SARS-CoV-2 in human serum and plasma on the ARCHITECT System (Abbott Laboratories, Chicago, IL). The assay measures IgG binding to the RBD of the S-protein ...
-
bioRxiv - Immunology 2022Quote: ... and anti-SARS-CoV-2 nucleocapsid IgG (6R86 ARCHITECT SARS-CoV-2 IgG) using a commercial ARCHITECT Abbott (Abbott Laboratories Diagnostics Division ...
-
bioRxiv - Immunology 2020Quote: ... to confirm absence of SARS-CoV-2 infection and by serology to confirm presence of anti-SARS-COV-2 IgG (Architect SARS-CoV-2 IgG assay, Abbott Ireland ...
-
bioRxiv - Immunology 2019Quote: ... Quantitative determination of TSH and TPOAb (only IgG class) levels was performed on the sera either by a chemiluminescent microparticle immunoassay (CMIA) [ARCHITECT® Anti-TPO or TSH (ABBOTT Diagnostics Division ...
-
bioRxiv - Microbiology 2021Quote: SARS-CoV-2 anti-nucleocapsid (N) IgG were determined using a commercially available immunoassay kit (Alinity SARS-CoV-2 IgG assay, Abbott Laboratories) according to the manufacturer’s instructions.
-
bioRxiv - Microbiology 2022Quote: ... HBeAg and anti-HBe in sera were measured by commercially available enzyme-linked immunosorbent assay kits (Abbott Laboratories, Chicago, IL, USA). HBsAg titers were quantified by use of Elecsys HBsAg II Quant reagent kits (Roche Diagnostics ...
-
bioRxiv - Immunology 2023Quote: Serum samples were analyzed for anti-S-RBD Hu-1 IgG titers with the SARS-CoV-2 IgG Quant II assay (ARCHITECT®, Abbott Laboratories). The latter assay is an automated chemiluminescence microparticle immunoassay (CMIA ...